Pre-market Hot Trades in US Stocks

TotalEnergies SE is down 3.41% in pre-market trading. Based on recent key news:

1. On July 24, TotalEnergies released its financial report for the first half of 2026, showing that its profits and revenues exceeded market expectations. Nevertheless, there remains uncertainty in the market regarding its future investments and production growth, leading to stock price volatility.

2. On July 25, TD Cowen analyst Jason Gabelman maintained a buy rating on TotalEnergies and set a target price of $105. However, Goldman Sachs maintained a hold rating, leading to market divergence regarding its future performance, which affects the stock price.

3. On July 27, TotalEnergies announced it would appeal the climate case ruling from the Paris Judicial Court on June 25. This move raised market concerns about its legal risks, further impacting the stock price. The energy sector has performed strongly recently, but legal risks are increasing.

Microchip Technology is up 3.39% in pre-market trading. Based on recent key news:

1. On July 24, Microchip Technology announced the acquisition of Hailo, although the terms of the deal were not disclosed, it is expected to have no significant impact on financial results. This move aims to expand its edge AI and visual processing technology portfolio, with the transaction expected to close by the end of the quarter on September 30. Source: Reuters

2. On July 24, Microchip Technology's Chief Operating Officer Richard J. Simoncic announced he would resign on August 17 to become the CEO of Menlo Microsystems. This personnel change may raise market concerns about the stability of the company's management. Source: SEC announcement

3. On July 24, Microchip Technology released a statement on its official website, emphasizing its technical support and solution capabilities across various markets, including industrial, automotive, and consumer electronics, further solidifying its market position. Source: Company website. The integration of AI technology in the industry is accelerating, increasing market attention.

Top Gainers in Pre-market US Stocks

Lion Group Holding is up 115.24% in pre-market trading. Based on recent key news:

1. On July 23, HRT Financial sold 34,989 shares of Lion Group Holding's common stock, leading to a decrease in its ownership percentage. This news may trigger market attention on the company's stock price, driving it up.

2. On July 24, Spark's AI analyst rated Lion Group Holding as neutral, mainly due to the company's poor financial performance, ongoing losses, and unstable revenues. Despite bearish technicals, market attention on the stock has increased, potentially driving stock price volatility.

3. On July 24, the Geene 2.0 ecosystem welcomed the domestic leading AI interactive marketing company Zhizhi Intelligent as a core partner, promoting the integration of AI live streaming technology with Southeast Asian market resources. This news may enhance market confidence in related technologies and companies, indirectly affecting Lion Group Holding's stock price The market's attention to AI technology and the Southeast Asian market is increasing.

Matinas BioPharma pre-market rose 61.35%. Based on recent key news:

1. On July 23, Matinas BioPharma announced the termination of its market sales agreement with BTIG. This agreement allowed the company to issue up to $50 million in common stock through the market. After terminating the agreement, the company lost an important financing channel, which may affect its future fundraising capabilities. Source: Reuters

2. On July 24, after BTIG terminated the sales agreement, Matinas BioPharma did not incur any termination fees or expenses. This move may alleviate investors' concerns about the company's financial burden, driving the stock price up. Source: SEC announcement

3. On July 25, analyst Spark rated Matinas BioPharma as neutral, mainly due to the company's weak financial performance and a still bearish technical outlook. Nevertheless, the market reacted positively to the company's strategic changes, leading to a significant rise in stock price. Source: TipRanks The biopharmaceutical industry has been volatile recently and requires attention.

T3 Defense pre-market rose 56.78%. Based on recent key news:

1. On July 24, T3 Defense submitted a SCHEDULE 13D filing, indicating that it is seeking a strategic share expansion. This move suggests that the company may pursue more acquisitions and management collaborations in the future, enhancing market confidence in its growth potential and driving the stock price significantly higher. Source: SEC announcement The market is optimistic about acquisition activities